MedPath

The impact of COVID19 pandemic-related activity restriction on the outcomes of chronic obstructive lung disease

Not Applicable
Conditions
chronic obstructive lung disease(COPD)
Registration Number
JPRN-UMIN000042106
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
122
Inclusion Criteria

Not provided

Exclusion Criteria

(1) cases who disagree with evaluation of COPD status (2) cases who investigators could not evaluate the incidence of COPD-related AE by medical record (3) cases carrying malignant tumors (4) cases with asthma

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Physical activity evaluated by IPAQ during COVID19 pandemic period
Secondary Outcome Measures
NameTimeMethod
1. Sedentary time during COVID19 pandemic period 2. Prevalence of COVID19 in this study population 3. The numbers of COPD-related acute exacerbation (AE) after COVID19 pandemic 4. The chance of spirometric valuables after COVID19 pandemic 5. Estimation of anxiety and depression evaluated by HADS on enroll 6. Identification of factors related to COPD-AE
© Copyright 2025. All Rights Reserved by MedPath